Pacira Pharmaceuticals Inc., of Parsippany, N.J., said it received a subpoena from the U.S. Department of Justice, U.S. Attorney's Office for the District of New Jersey, requiring a broad range of documents pertaining to marketing and promotional practices related to the product Exparel (bupivacaine liposome injectable suspension).